Combined Analysis of Phase III Trials Evaluating [(99m)Tc]Tilmanocept and Vital Blue Dye for Identification of Sentinel Lymph Nodes in Clinically Node-Negative Cutaneous Melanoma

Por Sondak, Vernon K., King, Dennis W., Zager, Jonathan S., Schneebaum, Schlomo, Kim, Julian, Leong, Stanley P. L., Faries, Mark B., Averbook, Bruce J., Martinez, Steve R., Puleo, Christopher A., Messina, Jane L., Christman, Lori, Wallace, Anne M.
Publicado em 2012

Comparative Evaluation of [(99m)Tc]Tilmanocept for Sentinel Lymph Node Mapping in Breast Cancer Patients: Results of Two Phase 3 Trials

Por Wallace, Anne M., Han, Linda K., Povoski, Stephen P., Deck, Kenneth, Schneebaum, Schlomo, Hall, Nathan C., Hoh, Carl K., Limmer, Karl K., Krontiras, Helen, Frazier, Thomas G., Cox, Charles, Avisar, Eli, Faries, Mark, King, Dennis W., Christman, Lori, Vera, David R.
Publicado em 2013

[(99m)Tc]Tilmanocept Accurately Detects Sentinel Lymph Nodes and Predicts Node Pathology Status in Patients with Oral Squamous Cell Carcinoma of the Head and Neck: Results of a Pha...

Por Agrawal, Amit, Civantos, Francisco J., Brumund, Kevin T., Chepeha, Douglas B., Hall, Nathan C., Carroll, William R., Smith, Russell B., Zitsch, Robert P., Lee, Walter T., Shnayder, Yelizaveta, Cognetti, David M., Pitman, Karen T., King, Dennis W., Christman, Lori A., Lai, Stephen Y.
Publicado no Ann Surg Oncol (2015)